Neuroradiological evaluation of demyelinating disease

Jan-Mendelt Tillema, Istvan Pirko

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.

Original languageEnglish (US)
Pages (from-to)249-268
Number of pages20
JournalTherapeutic Advances in Neurological Disorders
Volume6
Issue number4
DOIs
StatePublished - Jul 2013

Fingerprint

Demyelinating Diseases
Neuroimaging
Allergy and Immunology
Central Nervous System
Magnetic Resonance Imaging
Research

Keywords

  • demyelinating disease
  • MRI
  • multiple sclerosis
  • neuroimaging

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Pharmacology

Cite this

Neuroradiological evaluation of demyelinating disease. / Tillema, Jan-Mendelt; Pirko, Istvan.

In: Therapeutic Advances in Neurological Disorders, Vol. 6, No. 4, 07.2013, p. 249-268.

Research output: Contribution to journalArticle

@article{d6750f0b6022424b9cb75e66ab920ff8,
title = "Neuroradiological evaluation of demyelinating disease",
abstract = "Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.",
keywords = "demyelinating disease, MRI, multiple sclerosis, neuroimaging",
author = "Jan-Mendelt Tillema and Istvan Pirko",
year = "2013",
month = "7",
doi = "10.1177/1756285613478870",
language = "English (US)",
volume = "6",
pages = "249--268",
journal = "Therapeutic Advances in Neurological Disorders",
issn = "1756-2856",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Neuroradiological evaluation of demyelinating disease

AU - Tillema, Jan-Mendelt

AU - Pirko, Istvan

PY - 2013/7

Y1 - 2013/7

N2 - Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.

AB - Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.

KW - demyelinating disease

KW - MRI

KW - multiple sclerosis

KW - neuroimaging

UR - http://www.scopus.com/inward/record.url?scp=84880379925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880379925&partnerID=8YFLogxK

U2 - 10.1177/1756285613478870

DO - 10.1177/1756285613478870

M3 - Article

C2 - 23858328

AN - SCOPUS:84880379925

VL - 6

SP - 249

EP - 268

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

SN - 1756-2856

IS - 4

ER -